SCHEMBL24065255

SCHEMBL24065255

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-n4c5ccc(-c6ccccc6)cc5c5cc(-c6ccccc6)ccc54)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.43
▸ KMT2A Q03164 5/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ NR4A2 P43354 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ GLA P06280 1/20 0.38
▸ LDHA P00338 1/20 0.37
▸ ADORA2A P29274 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ EGLN1 Q9GZT9 2/20 0.37
▸ NR3C1 P04150 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228054 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16191494 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL30118225 0.98 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21163584 0.98 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL10057916 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21388898 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19928006 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL12117356 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL10057005 0.97 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16234055 0.97 MEN1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230119201-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-04-20 — — US disclosed
US-20220006029-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-01-06 — — US disclosed
US-20210380534-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-12-09 — — US disclosed
US-20210376245-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380534-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OCIAD2, OSTC MEN1 3271/4885KMT2A 4522/4885ALDH1A1 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback